欧洲生命科学工具与试剂市场

生命科学工具、试剂和 COVID-19 诊断产品的市场规模预计将从 2032 年的 147 亿美元成长到 2024 年的 130 亿美元，预测期内复合年增长率为 3.4%，到年终将达到154 亿美元。

生命科学工具和试剂产业预计将从 2024 年的 125 亿美元成长到 2029年终的153 亿美元，复合年增长率为 4.2%。此外，生命科学COVID-19诊断产品领域预计将从2024年的4.796亿美元成长到2029年终的2,940万美元，复合年增长率为-42.8%。

本报告调查了欧洲生命科学工具和试剂市场，并提供了市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测以及各种细分。编译详细的区域分析、竞争格局、主要企业简介等。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场概况

第二章 市场概况

• 概述
• 生命科学领域的产品开发

第三章市场动态

• 世界市场动态
• 市场驱动因素
• 加大研发投入
• 慢性病增加
• 对不同诊断途径和体外诊断的需求不断增加
• 基因组和生物标记研究的成长
• 对个人化医疗的需求不断增加
• 技术进步
• 市场限制因素
• COVID-19 大流行结束
• 设备高成本
• 缺乏熟练人才
• 市场挑战
• 监管障碍
• 市场机会
• 药品法部分修改的正面影响
• 新技术

第四章新兴科技与发展

• 概述
• 下一代疗法
• 下一代诊断
• 数位化
• 人工智慧和机器学习
• IoT
• 生命科学实验室中的机器人

第五章市场区隔分析

• 概述
• 细分细分
• 欧洲生命科学工具与试剂市场：依产品类型
• COVID-19 诊断测试市场
• 生命科学工具和试剂市场
• 欧洲生命科学工具与试剂市场：依应用分类
• 基因组学
• 蛋白质体学
• 细胞生物学/抗体/重组蛋白
• 干细胞研究
• 影像工具和技术
• 动物模型
• 表观遗传学
• 代谢体学
• 其他的
• 欧洲
• 英国
• 德国
• 法国
• 瑞士
• 西班牙
• 义大利
• 其他的

第六章 竞争讯息

• PCR技术与试剂
• 抗体
• 酵素连结免疫吸附设备
• ELISA套件和检测
• 生命科学试剂套件和检测
• COVID-19 诊断
• 策略倡议
• 近期市场上推出的产品

第七章欧洲生命科学工具与试剂市场的永续性：ESG 视角

• ESG：简介
• 产业ESG实践
• ESG产业现状
• BCC的结语

第8章附录

• 调查方法
• 缩写词
• 来源
• 公司简介
• AGILENT TECHNOLOGIES INC.
• ALTONA DIAGNOSTICS GMBH
• ANALYTIK JENA GMBH+CO. KG
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY INC.
• THERMO FISHER SCIENTIFIC INC.

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

The European market for life science tools and reagents is expected to grow from $12.5 billion in 2024 to $15.3 billion by the end of 2029, at a CAGR of 4.2% from 2024 through 2029.

The European market for life science COVID-19 diagnostics products is expected to decline from $479.6 million in 2024 to $29.4 million by the end of 2029, at a negative CAGR of 42.8% from 2024 through 2029.

Report Scope

This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.

Report Includes

• 33 data tables and 54 additional tables
• An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
• Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Product Development in Life Science

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Increasing Investments in R&D
• Increasing Prevalence of Chronic Diseases
• Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
• Growth in Genomic and Biomarker Research
• Increasing Demand for Personalized Medicine
• Technological Advances
• Market Restraints
• End of COVID-19 Pandemic
• High Cost of Instruments
• Lack of Skilled Personnels
• Market Challenges
• Regulatory Hurdles
• Market Opportunities
• Positive Impact from Some Revisions in Pharmaceutical Legislation
• New Technologies

Chapter 4 Emerging Technologies and Developments

• Overview
• Next-Generation Therapeutics
• Next-Generation Diagnostics
• Digitalization
• AI and Machine Learning
• Internet of Things (IoT)
• Robots in Life Science Labs

Chapter 5 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• European Market for Life Science Tools and Diagnostics, by Product Type
• COVID-19 Diagnostic Tests Market
• Market for Life Science Tools and Reagents
• European Market for Life Science Tools and Diagnostics, by Application
• Genomics
• Proteomics
• Cell Biology, Antibodies and Recombinant Proteins
• Stem Cells Research
• Imaging Tools and Techniques
• Animal Models
• Epigenetics
• Metabolomics
• Other Applications
• Europe
• United Kingdom
• Germany
• France
• Switzerland
• Spain
• Italy
• Rest of Europe

Chapter 6 Competitive Intelligence

• PCR Technologies and Reagents
• Antibodies
• ELISA Instruments
• ELISA Kits and Assays
• Life Science Kits and Assays
• COVID-19 Diagnostics
• Strategic Initiatives
• Recent Product Introductions in the Market

Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective

• Introduction to ESG
• ESG Practices in the Industry
• Status of ESG in the Industry
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Acronyms
• Sources
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ALTONA DIAGNOSTICS GMBH
• ANALYTIK JENA GMBH+CO. KG
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY INC.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
• Table 1 : Differences Between Basic and Applied Research
• Table 2 : Pharmaceutical Industry R&D Expenditures in Europe, by Select Countries, 2022
• Table 3 : Cancer Cases in Europe for Both Sexes, 2022
• Table 4 : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
• Table 5 : European Market for COVID-19 Diagnostics Tests, by Type, Through 2029
• Table 6 : European Market for COVID-19 Molecular Tests, by Country, Through 2029
• Table 7 : European Market for COVID-19 Antigen Tests, by Country, Through 2029
• Table 8 : European Market for COVID-19 Serological Tests, by Country, Through 2029
• Table 9 : European Market for Life Science Tools and Reagents, by Type, Through 2029
• Table 10 : European Market for Life Science Instruments, by Country, Through 2029
• Table 11 : European Market for Life Science Reagents and Kits, by Country, Through 2029
• Table 12 : European Market for Life Science Tools and Reagents, by Application, Through 2029
• Table 13 : European Market for Genomics, by Country, Through 2029
• Table 14 : Drug Targets Identified by Proteomics
• Table 15 : European Market for Proteomics, by Country, Through 2029
• Table 16 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
• Table 17 : European Market for Stem Cell Research, by Country, Through 2029
• Table 18 : European Market for Imaging Tools and Techniques, by Country, Through 2029
• Table 19 : European Market for Animal Models, by Country, Through 2029
• Table 20 : European Market for Epigenetics, by Country, Through 2029
• Table 21 : European Market for Metabolomics, by Country, Through 2029
• Table 22 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
• Table 23 : European Based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
• Table 24 : European Market for Life Science Tools and Reagents, by Country, Through 2029
• Table 25 : European Market for Life Science COVID-19 Diagnostics Tests, by Country, Through 2029
• Table 26 : Ranking of Life Science Tool and Reagent Companies in Europe, 2023
• Table 27 : Leading Providers of PCR Technologies, by Revenue, 2023
• Table 28 : Leading Suppliers of Research Antibodies, 2023
• Table 29 : Leading Providers of ELISA Instruments/Microplate Readers, 2023
• Table 30 : Leading Providers of ELISA Kits and Assays, 2023
• Table 31 : Ranking of Leading Suppliers of Kits and Assays, 2023
• Table 32 : Ranking of Leading Providers of COVID-19 Diagnostics Tools, 2023
• Table 33 : Collaborations in the Life Science Tools and Reagents Market, 2020-2024
• Table 34 : Mergers and Acquisitions in the Life Science Tools and Reagents Market, 2021-2024
• Table 35 : Recent New Life Science Tools and Reagents, 2021-2024
• Table 36 : Key Focus Areas in ESG Metrics
• Table 37 : Environmental Initiatives by Various Life Science Tools, Reagents and Diagnostics Companies and Some of their Initiatives in Europe
• Table 38 : Key Social and Governance Issues in the Life Science Tools, Reagents and Diagnostics Industry
• Table 39 : ESG Rankings for Companies in the Life Science Tools and Reagents Market, 2023
• Table 40 : Glossary of Terms Used in This Report
• Table 41 : Information Sources in This Report
• Table 42 : Agilent Technologies Inc.: Company Snapshot
• Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 44 : Agilent Technologies Inc.: Product Portfolio
• Table 45 : Agilent Technologies Inc.: News/Key Developments, 2023
• Table 46 : Altona Diagnostic GmbH.: Company Snapshot
• Table 47 : Altona Diagnostic GmbH: Product Portfolio
• Table 48 : Altona Diagnostic GmbH: News/Key Developments, 2021-2023
• Table 49 : Analytik Jena GmbH+Co KG: Company Snapshot
• Table 50 : Analytik Jena GmbH+Co KG: Product Portfolio
• Table 51 : Analytik Jena GmbH+Co KG: News/Key Developments, 2023
• Table 52 : BD: Company Snapshot
• Table 53 : BD: Financial Performance, FY 2022 and 2023
• Table 54 : BD: Product Portfolio
• Table 55 : BD: News/Key Developments, 2021-2024
• Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
• Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
• Table 60 : Danaher Corp.: Company Snapshot
• Table 61 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 62 : Danaher Corp.: Product Portfolio
• Table 63 : Danaher Corp.: News/Key Developments, 2021-2023
• Table 64 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 65 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 66 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 67 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2023
• Table 68 : Merck KGaA: Company Snapshot
• Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 70 : Merck KGaA.: Product Portfolio
• Table 71 : Merck KGaA: News/Key Developments, 2021-2024
• Table 72 : Promega Corp.: Company Snapshot
• Table 73 : Promega Corp.: Product Portfolio
• Table 74 : Promega Corp.: News/Key Developments, 2023 and 2024
• Table 75 : Qiagen: Company Snapshot
• Table 76 : Qiagen: Financial Performance, FY 2022 and 2023
• Table 77 : Qiagen: Product Portfolio
• Table 78 : Qiagen: News/Key Developments, 2023
• Table 79 : Revvity Inc.: Company Snapshot
• Table 80 : Revvity Inc.: Financial Performance, FY 2022 and 2023
• Table 81 : Revvity Inc.: Product Portfolio
• Table 82 : Revvity Inc.: News/Key Developments, 2023 and 2024
• Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

• Summary Figure : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, 2021-2029
• Figure 1 : Market Dynamics of European Life Science Tools and Reagents Market
• Figure 2 : New Diagnostic Techniques
• Figure 3 : Comparison of New Active Substances Approvals
• Figure 4 : Comparison of European Patent Applications and Granted Patents, by Technical Field, 2011-2022
• Figure 5 : European Market Shares of COVID-19 Diagnostics Tests, by Type, 2023
• Figure 6 : European Market Shares of Life Science Tools and Reagents, by Type, 2023
• Figure 7 : Types of ELISA
• Figure 8 : Firms and R&D Investment in Health Industries, 2012 and 2022
• Figure 9 : Pharmaceutical Pipeline Activity and Key Therapeutic Areas in Europe, 2022
• Figure 10 : The U.K. Market for Life Science Tools and Reagents, 2024-2029
• Figure 11 : German Market for Life Science Tools and Reagents, 2021-2029
• Figure 12 : French Market for Life Science Tools and Reagents, 2021-2029
• Figure 13 : Swiss Market for Life Science Tools and Reagents, 2024-2029
• Figure 14 : Spanish Market for Life Science Tools and Reagents, 2024-2029
• Figure 15 : Italian Market for Life Science Tools and Reagents, 2021-2029
• Figure 16 : Rest of the European Market for Life Science Tools and Reagents, 2021-2029
• Figure 17 : EPFIA's Environmental Sustainability Measures
• Figure 18 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 19 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 20 : BD: Revenue Share, by Business Unit, FY 2023
• Figure 21 : BD: Revenue Share, by Country/Region, FY 2023
• Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 28 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Qiagen: Revenue Share, by Business Unit, FY 2023
• Figure 31 : Qiagen: Revenue Share, by Country/Region, FY 2023
• Figure 32 : Revvity Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 33 : Revvity Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023